Viewing Study NCT02828033


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-03-05 @ 2:31 PM
Study NCT ID: NCT02828033
Status: UNKNOWN
Last Update Posted: 2017-09-13
First Post: 2016-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
Sponsor: Stanley Cohen
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Rilonacept IIS 1604
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View